583 related articles for article (PubMed ID: 4631683)
1. Single-agent therapy for Hodgkin's disease.
Carter SK; Livingston RB
Arch Intern Med; 1973 Mar; 131(3):377-87. PubMed ID: 4631683
[No Abstract] [Full Text] [Related]
2. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
DeVita VT
Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
[No Abstract] [Full Text] [Related]
3. Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
Nissen NI; Stutzman L; Holland JF; Glidewell OJ
Arch Intern Med; 1973 Mar; 131(3):396-401. PubMed ID: 4688038
[No Abstract] [Full Text] [Related]
4. [Hodgkin's disease in the practice of general medicine. Problems posed by the diagnosis, surveillance of treatments and social rehabilitation of patients].
Huart M
Rev Prat; 1974 Oct; 24(45):3995-8. PubMed ID: 4216953
[No Abstract] [Full Text] [Related]
5. [Cytostatic chemotherapy in lymphogranulomatosis].
Stacher A
Med Klin; 1973 Jul; 68(30):985-8. PubMed ID: 4131695
[No Abstract] [Full Text] [Related]
6. Treatment of Hodgkin's disease and other malignant lymphomas.
Aungst CW
J Surg Oncol; 1973 Jun; 5(6):575-9. PubMed ID: 4589653
[No Abstract] [Full Text] [Related]
7. [Indications for immunosuppressive treatment in kidney diseases of children].
Wojnarowski M; Wyszyńska T
Pediatr Pol; 1969 May; 44(5):525-30. PubMed ID: 4183009
[No Abstract] [Full Text] [Related]
8. Guide to the use of cancer chemotherapeutic agents.
Bergevin PR; Tormey DC; Blom J
Mod Treat; 1972 May; 9(2):185-273. PubMed ID: 4117324
[No Abstract] [Full Text] [Related]
9. The sensitivity of Hodgkin's disease to chemotherapeutic agents administered singly.
Desser RK; Ultmann JE
Ser Haematol; 1973; 6(2):152-81. PubMed ID: 4131662
[No Abstract] [Full Text] [Related]
10. The treatment of Hodgkin's disease.
Fairley GH
Trans Med Soc Lond; 1972; 88():61-71. PubMed ID: 4665820
[No Abstract] [Full Text] [Related]
11. Current chemotherapeutic combinations.
DeVita VT; Carbone PP
Ser Haematol; 1973; 6(2):182-95. PubMed ID: 4593779
[No Abstract] [Full Text] [Related]
12. [Drug therapy of cervical cancer].
Dekster LI
Vopr Onkol; 1974; 20(8):94-102. PubMed ID: 4215223
[No Abstract] [Full Text] [Related]
13. [Drug therapy of malignant lymphoma].
Ogawa M; Inagaki J
Rinsho Hoshasen; 1985 Oct; 30(11):1317-32. PubMed ID: 2418229
[No Abstract] [Full Text] [Related]
14. Status and perspectives in chemotherapy of Hodgkin's disease.
Frei E
Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
[No Abstract] [Full Text] [Related]
15. Prognosis and survival with extranodal Hodgkin's disease.
McLaren JH; Papac RJ
J Chronic Dis; 1974 Nov; 27(9-10):447-57. PubMed ID: 4139168
[No Abstract] [Full Text] [Related]
16. Cytotoxic agents in the treatment of malignant disease.
Br Med J; 1968 Nov; 4(5628):438-9. PubMed ID: 4972069
[No Abstract] [Full Text] [Related]
17. [Current status of chemotherapy of malignant tumors of the ovaries].
Nechaeva ID
Vopr Onkol; 1968; 14(6):108-22. PubMed ID: 4972640
[No Abstract] [Full Text] [Related]
18. [Drug therapy of lymphogranulomatosis].
Lorie IuI; Kondrat'eva AP; Kaverzneva MM
Med Radiol (Mosk); 1973 May; 18(5):32-7. PubMed ID: 4769901
[No Abstract] [Full Text] [Related]
19. [Antineoplastic chemotherapy in dermatology. Clinical experimental and anatomico pathologic study on the activities of some antimitotics. Findings in the general and local therapy].
Scotti G
Omnia Med Ther; 1970; 48(3):209-348. PubMed ID: 4108231
[No Abstract] [Full Text] [Related]
20. Combination chemotherapy of advanced Hodgkin's disease. A review.
Goldsmith MA; Carter SK
Cancer; 1974 Jan; 33(1):1-8. PubMed ID: 4129559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
